Trial · NCT01908205
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Function | 12 and 24 weeks | units on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Cognition | 12 Weeks | score on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Cognition | 12 Weeks | units on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Function | 12 Weeks | score on a scale | MEAN | |
| SECONDARY | Number of Participant Considered Social Responders | 12 Weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Repetitive Behaviors | 12 Weeks | units on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Repetitive Behaviors | 12 Weeks | units on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Anxiety | 12 Weeks | units on a scale | MEAN | |
| SECONDARY | Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Quality of Life | 12 Weeks | score on a scale | MEAN | |
| SECONDARY | Number of Participant Considered Overall Responders | 12 Weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Safety and Tolerability of Intranasal Oxytocin in Children and Adolescents With ASD | 12 Weeks | Of the original 60 participants enrolled at baseline, 6 participants dropped from the study, and none experienced SAEs | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01908205/outcomes